| Year |
Citation |
Score |
| 2024 |
Aroni S, Sagheddu C, Pistis M, Muntoni AL. Functional Adaptation in the Brain Habenulo-Mesencephalic Pathway During Cannabinoid Withdrawal. Cells. 13. PMID 39513916 DOI: 10.3390/cells13211809 |
0.522 |
|
| 2023 |
Sagheddu C, Cancedda E, Bagheri F, Kalaba P, Muntoni AL, Lubec J, Lubec G, Sanna F, Pistis M. The atypical dopamine transporter inhibitor CE-158 enhances dopamine neurotransmission in the prefrontal cortex of male rats: a behavioral, electrophysiological and microdialysis study. The International Journal of Neuropsychopharmacology. PMID 37725477 DOI: 10.1093/ijnp/pyad056 |
0.609 |
|
| 2023 |
Requie LM, Gómez-Gonzalo M, Speggiorin M, Managò F, Melone M, Congiu M, Chiavegato A, Lia A, Zonta M, Losi G, Henriques VJ, Pugliese A, Pacinelli G, Marsicano G, Papaleo F, ... Muntoni AL, et al. Author Correction: Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons. Nature Neuroscience. PMID 37186120 DOI: 10.1038/s41593-023-01330-7 |
0.402 |
|
| 2023 |
Santoni M, Sagheddu C, Serra V, Mostallino R, Paola Castelli M, Pisano F, Scherma M, Fadda P, Muntoni AL, Zamberletti E, Rubino T, Melis M, Pistis M. Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. Brain, Behavior, and Immunity. PMID 36746342 DOI: 10.1016/j.bbi.2023.02.002 |
0.742 |
|
| 2022 |
Murru E, Muntoni AL, Manca C, Aroni S, Pistis M, Banni S, Carta G. Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice. International Journal of Molecular Sciences. 24. PMID 36614161 DOI: 10.3390/ijms24010709 |
0.523 |
|
| 2022 |
Requie LM, Gómez-Gonzalo M, Speggiorin M, Managò F, Melone M, Congiu M, Chiavegato A, Lia A, Zonta M, Losi G, Henriques VJ, Pugliese A, Pacinelli G, Marsicano G, Papaleo F, ... Muntoni AL, et al. Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons. Nature Neuroscience. 25: 1639-1650. PMID 36396976 DOI: 10.1038/s41593-022-01193-4 |
0.49 |
|
| 2021 |
Sagheddu C, Melis M, Muntoni AL, Pistis M. Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders. Pharmaceuticals (Basel, Switzerland). 14. PMID 34681249 DOI: 10.3390/ph14101025 |
0.676 |
|
| 2021 |
Congiu M, Micheli L, Santoni M, Sagheddu C, Muntoni AL, Makriyannis A, Malamas MS, Ghelardini C, Di Cesare Mannelli L, Pistis M. N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34553321 DOI: 10.1007/s13311-021-01116-4 |
0.595 |
|
| 2020 |
Santoni M, Congiu M, Sagheddu C, Muntoni A, Makriyannis A, Malamas M, Di Cesare Mannelli L, Pistis M. P.204 Effect of N-acylethanolamine acid amidase inhibition on locus coeruleus noradrenergic neuronal responses to morphine European Neuropsychopharmacology. 31: S21-S22. DOI: 10.1016/J.Euroneuro.2019.12.030 |
0.426 |
|
| 2019 |
Lecca S, Luchicchi A, Scherma M, Fadda P, Muntoni AL, Pistis M. Δ-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation. Frontiers in Behavioral Neuroscience. 13: 202. PMID 31551729 DOI: 10.3389/Fnbeh.2019.00202 |
0.681 |
|
| 2018 |
De Felice M, Melis M, Aroni S, Muntoni AL, Fanni S, Frau R, Devoto P, Pistis M. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics. PMID 30461214 DOI: 10.1111/cns.13087 |
0.699 |
|
| 2017 |
Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. PMID 28766701 DOI: 10.1111/epi.13863 |
0.673 |
|
| 2016 |
Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 110: 251-259. PMID 27457507 DOI: 10.1016/j.neuropharm.2016.07.024 |
0.747 |
|
| 2016 |
Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal immune activation disrupts dopamine system in the offspring. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26819283 DOI: 10.1093/Ijnp/Pyw007 |
0.708 |
|
| 2016 |
Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology. PMID 26728894 DOI: 10.1007/S00213-015-4196-3 |
0.659 |
|
| 2016 |
De Felice M, Aroni S, Muntoni A, Frau R, Fanni S, Pardu A, Devoto P, Pistis M. P.4.010 Effects of maternal immune activation on dopamine activity in male and female offspring European Neuropsychopharmacology. 26: S93-S94. DOI: 10.1016/S0924-977X(16)70100-3 |
0.605 |
|
| 2015 |
Sagheddu C, Muntoni AL, Pistis M, Melis M. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. International Review of Neurobiology. 125: 257-302. PMID 26638769 DOI: 10.1016/bs.irn.2015.10.004 |
0.727 |
|
| 2015 |
Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26388146 DOI: 10.1038/Npp.2015.295 |
0.655 |
|
| 2015 |
Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology. 97: 383-93. PMID 26113399 DOI: 10.1016/J.Neuropharm.2015.06.003 |
0.744 |
|
| 2014 |
Melis M, Sagheddu C, De Felice M, Casti A, Madeddu C, Spiga S, Muntoni AL, Mackie K, Marsicano G, Colombo G, Castelli MP, Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12716-24. PMID 25232109 DOI: 10.1523/Jneurosci.1844-14.2014 |
0.754 |
|
| 2013 |
Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, Scheggi S, Carta G, Murru E, Aroni S, Muntoni AL, Pistis M. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. Plos One. 8: e64541. PMID 23724059 DOI: 10.1371/journal.pone.0064541 |
0.704 |
|
| 2012 |
Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Frontiers in Pharmacology. 3: 7. PMID 22347186 DOI: 10.3389/fphar.2012.00007 |
0.765 |
|
| 2012 |
Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1164-76. PMID 22169942 DOI: 10.1038/Npp.2011.302 |
0.799 |
|
| 2011 |
Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 589-602. PMID 21048703 DOI: 10.1038/Npp.2010.190 |
0.793 |
|
| 2010 |
Luchicchi A, Lecca S, Carta S, Pillolla G, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addiction Biology. 15: 277-88. PMID 20477753 DOI: 10.1111/J.1369-1600.2010.00222.X |
0.733 |
|
| 2009 |
Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology. 201: 471-81. PMID 18777018 DOI: 10.1007/s00213-008-1309-2 |
0.746 |
|
| 2008 |
Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13985-94. PMID 19091987 DOI: 10.1523/Jneurosci.3221-08.2008 |
0.754 |
|
| 2007 |
Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology. 191: 843-53. PMID 17334799 DOI: 10.1007/s00213-007-0733-z |
0.829 |
|
| 2007 |
Pillolla G, Perra S, Melis M, Muntoni A, Pistis M. P.1.20 Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate European Neuropsychopharmacology. 17: S18. DOI: 10.1016/S0924-977X(07)70021-4 |
0.743 |
|
| 2006 |
Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiology of Disease. 24: 15-27. PMID 16762556 DOI: 10.1016/J.Nbd.2006.04.010 |
0.82 |
|
| 2006 |
Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. The European Journal of Neuroscience. 23: 2385-94. PMID 16706846 DOI: 10.1111/j.1460-9568.2006.04759.x |
0.809 |
|
| 2006 |
Pistis M, Perra S, Pillolla G, Muntoni A, Melis M. P.6.b.001 The endocannabinoid system in the effects of alcohol on limbic neurons:an in vivo electrophysiological study European Neuropsychopharmacology. 16: S496-S497. DOI: 10.1016/S0924-977X(06)70672-1 |
0.679 |
|
| 2005 |
Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology. 183: 368-77. PMID 16228194 DOI: 10.1007/s00213-005-0195-0 |
0.801 |
|
| 2005 |
Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience. 131: 465-74. PMID 15708487 DOI: 10.1016/j.neuroscience.2004.11.021 |
0.791 |
|
| 2004 |
Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10707-15. PMID 15564588 DOI: 10.1523/Jneurosci.3502-04.2004 |
0.811 |
|
| 2004 |
Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 56: 86-94. PMID 15231440 DOI: 10.1016/j.biopsych.2004.05.006 |
0.825 |
|
| 2004 |
Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 53-62. PMID 14715937 DOI: 10.1523/JNEUROSCI.4503-03.2004 |
0.803 |
|
| 2004 |
Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 46: 115-25. PMID 14654103 DOI: 10.1016/j.neuropharm.2003.08.003 |
0.822 |
|
| 2003 |
Diana M, Brodie M, Muntoni A, Puddu MC, Pillolla G, Steffensen S, Spiga S, Little HJ. Enduring effects of chronic ethanol in the CNS: basis for alcoholism. Alcoholism, Clinical and Experimental Research. 27: 354-61. PMID 12605085 DOI: 10.1097/01.Alc.0000057121.36127.19 |
0.742 |
|
| 2002 |
Pistis M, Muntoni AL, Pillolla G, Gessa GL. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. The European Journal of Neuroscience. 15: 1795-802. PMID 12081659 DOI: 10.1046/j.1460-9568.2002.02019.x |
0.795 |
|
| 2001 |
Gobbi G, Muntoni AL, Gessa GL, Diana M. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal. Psychopharmacology. 158: 1-6. PMID 11685378 DOI: 10.1007/S002130100832 |
0.839 |
|
| 1999 |
Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. The European Journal of Neuroscience. 11: 1037-41. PMID 10103095 DOI: 10.1046/j.1460-9568.1999.00488.x |
0.838 |
|
| 1998 |
Diana M, Melis M, Muntoni AL, Gessa GL. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 95: 10269-73. PMID 9707636 DOI: 10.1073/pnas.95.17.10269 |
0.844 |
|
| 1998 |
Gessa GL, Melis M, Muntoni AL, Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology. 341: 39-44. PMID 9489854 DOI: 10.1016/S0014-2999(97)01442-8 |
0.821 |
|
| 1997 |
Pistis M, Muntoni AL, Gessa G, Diana M. Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience. 79: 171-6. PMID 9178873 DOI: 10.1016/S0306-4522(96)00643-4 |
0.819 |
|
| 1996 |
Diana M, Pistis M, Muntoni A, Gessa G. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neuroscience. 71: 411-5. PMID 9053796 DOI: 10.1016/0306-4522(95)00482-3 |
0.814 |
|
| 1996 |
Diana M, Muntoni AL, Pistis M, Collu M, Forgione A, Gessa GL. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity. European Journal of Pharmacology. 312: 179-81. PMID 8894593 DOI: 10.1016/0014-2999(96)00581-X |
0.803 |
|
| 1996 |
Muntoni AL, Diana M, Gessa GL. Repeated naltrexone administration accelerates resolution of morphine somatic withdrawal signs in morphine-dependent rats. European Journal of Pharmacology. 301: R9-10. PMID 8773469 DOI: 10.1016/0014-2999(96)00126-4 |
0.731 |
|
| 1995 |
Mereu G, Lilliu V, Vargiu P, Muntoni AL, Diana M, Gessa GL. Depolarization inactivation of dopamine neurons: an artifact? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1144-9. PMID 7869090 DOI: 10.1523/Jneurosci.15-02-01144.1995 |
0.796 |
|
| 1995 |
Diana M, Pistis M, Muntoni A, Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. The Journal of Pharmacology and Experimental Therapeutics. 272: 781-5. PMID 7853194 |
0.824 |
|
| 1995 |
Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse (New York, N.Y.). 20: 153-5. PMID 7570345 DOI: 10.1002/syn.890200209 |
0.816 |
|
| 1995 |
Diana M, Pistis M, Muntoni AL, Gessa GL. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system. Brain Research. 682: 29-34. PMID 7552323 DOI: 10.1016/0006-8993(95)00292-X |
0.842 |
|
| 1995 |
Diana M, Pistis M, Muntoni AL, Collu M, Forgione A, Gossa GL. Plasticity changes in dopamine autoreceptor function after chronic L-sulpiride Behavioural Pharmacology. 6: 19. DOI: 10.1097/00008877-199505001-00020 |
0.727 |
|
| 1994 |
Mereu G, Lilliu V, Vargiu P, Muntoni AL, Diana M, Gessa GL. Failure of chronic haloperidol to induce depolarization inactivation of dopamine neurons in unanesthetized rats. European Journal of Pharmacology. 264: 449-53. PMID 7698187 DOI: 10.1016/0014-2999(94)00545-1 |
0.822 |
|
| 1993 |
Diana M, Pistis M, Muntoni A, Gessa G. Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration. European Journal of Pharmacology. 230: 363-5. PMID 8440312 DOI: 10.1016/0014-2999(93)90574-2 |
0.831 |
|
| 1992 |
Diana M, Pistis M, Muntoni A, Rossetti ZL, Gessa G. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. European Journal of Pharmacology. 221: 403-4. PMID 1426019 DOI: 10.1016/0014-2999(92)90734-L |
0.804 |
|
| 1992 |
Diana M, Pistis M, Muntoni A, Gessa GL. Electrophysiological effects of acute and chronic ethanol administration Pharmacological Research. 26: 216. DOI: 10.1016/1043-6618(92)91142-4 |
0.707 |
|
| Show low-probability matches. |